World Congestive Heart Failure (CHF) Treatment Devices Market is expected to reach $14.8 Billion by 2022; Finds New Report

"Congestive Heart Failure (CHF) Treatment Devices Market" projects that the world CHF treatment devices market would reach $14.8 billion by 2022, at a CAGR of 5.5% from 2016 to 2022. Implantable cardioverter-defibrillator (ICDs) segment is expected to dominate the world CHF treatment devices market throughout the forecast period. North America is projected to continue its lead in terms of revenue, accounting for more than two-fifths share of the world CHF treatment devices.

The major factors boosting the market growth include the growing incidence of heart failures, technological advancements in CHF treatment devices, and increasing adoption rates for these devices. In addition, rising incidence of diabetes, atherosclerosis, strokes, hypertension, and others due to faulty lifestyle habits such as unhealthy dietary habits, lack of physical activity, and smoking, among others are the leading causes of congestive heart failure. Rising geriatric population base is expected to fuel the prevalence of congestive heart failures thereby augmenting the market growth. Presence of huge unmet medical needs and rising emphasis on early intervention and primary prevention of heart failures are also anticipated to drive the demand for these devices. However, high cost of these devices and unfavorable reimbursement scenario in the emerging countries are some of the factors that restrict the market growth.

The Implantable Cardioverter Defibrillators (ICDs) segment would maintain its lead in the market throughout the analysis period, primarily because of the increasing number of patients with faster-than-normal rhythm as the mean age of the global population is shifting towards older age groups. Ventricular assist devices (VADs) has emerged as the fastest growing segment, with a CAGR of 11.9%. Increasing focus on the development of advanced VDAs and miniaturization of VADs are the major factors responsible for the growth of this market.

Key findings of the study:

• In 2015, ICDs accounted for almost one-third of the overall market revenue, and is projected to grow at a CAGR of 4.8% during the forecast period.
• The VADs segment is likely to grow at a remarkable CAGR of 11.9%, owing to the innovation and miniaturization of devices.
• North America accounted for over 40% share of the world CHF treatment devices market in 2015.
• The U.S. is projected to maintain its lead in the world CHF treatment devices market until 2022.
• China and Japan are the major shareholders in the Asia-Pacific region, jointly accounting for almost half of share in the Asia-Pacific market.

Geographically, North America accounted for the majority of the share in the world CHF treatment devices market in 2015, and is expected to maintain this lead throughout the forecast period. This was mainly attributed to the increasing incidence of heart failures, presence of highly sophisticated healthcare infrastructure, and adoption of advanced CHF treatment devices in the North American countries. However, Asia-Pacific is expected to be the fastest growing region throughout the analysis period, owing to ample growth opportunities in terms of unmet medical needs for the treatment of cardiac disorders in these regions.

The key players profiled include Abiomed, Inc., Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International, Inc., Jarvik Heart, Inc., LivaNova PLC, Medtronic plc, ReliantHeart Inc., and St. Jude Medical, Inc.

For more information Visit at: http://mrr.cm/JXZ

Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare

Cardiac Rhythm Management Devices Market in China to grow at a CAGR of 10.1% during the period 2016 - 2020; Finds New Report

Report forecast the cardiac rhythm management devices market in China to grow at a CAGR of 10.1% during the period 2016-2020.

Cardiac rhythm management or electrophysiology therapy helps diagnose and treat heart disorders that cause rhythm complications. These disorders include bradycardia and tachycardia that affect the heart's electrical system. These disorders cause irritation in the heart muscles, causing abnormal heart functions. This can occur during heart attacks. Devices such as ICDs, CRT systems, and biventricular pacemakers help manage these disorders.

The report covers the present scenario and the growth prospects of the cardiac rhythm management devices market in China 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of pacemakers, ICTs, and CRT devices.

According to the report, one driver fostering the prospects for growth in this market will be the increase in joint ventures. Strict product approval processes and safety regulations with regard to medical devices make it hard for international vendors to enter the market in China. The country is frequently amending its regulations to provide a safe and better healthcare system. China is also encouraging local manufacturers to develop advanced medical devices.

Further, the report states that the preference for open surgeries will impede market growth until the end of the forecast period. Minimally invasive procedures help prevent excessive blood loss, cause minimal pain and scarring, reduce the duration of recovery and hospital stay, and lead to better medical outcomes. However, these procedures are limited to Tier I and some of Tier II medical facilities such as hospitals and clinics in China. Tier III hospitals cater to rural areas. These hospitals do not have advanced facilities and experienced surgeons to conduct sophisticated minimally invasive procedures for cardiac rhythm management. As a result, people in these hospitals undergo open surgeries for cardiac rhythm management.

Cardiac Rhythm Management Devices Market in China 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the cardiac rhythm management devices market in China: BIOTRONIK, Boston Scientific, LivaNova, and Medtronic.

Other Prominent Vendors in the market are: Anjue Medical Equipment, Beijing Carejoy Technology, Cardiac Science (a subsidiary of Opto Circuits), CardiAid, E&M Electromedicina, EMTEL, Fukuda Denshi, Guangzhou Leyte Electronic, Guangzhou Maya Medical Equipment, Guangzhou Yueshan Medical Equipment, Hagenuk, Instramed, Lepu Medical Technology (Beijing), Mindray Medical International, Perlong Medical Equipment, Physio Control, Poweam Medical, and Wincom.

Market driver

• Prevalence of cardiac disorders
• For a full, detailed list, view our report

Market challenge

• Promotion of locally manufactured products
• For a full, detailed list, view our report

Market trend

• Popularity of robot-assisted cardiac surgery
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 66 pages and 33 Exhibit “Cardiac Rhythm Management Devices Market in China 2016 - 2020” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Healthcare reform in China, Regulatory landscape, Insurance coverage and reimbursement in China, Opportunities for global and local vendors, Market segmentation by product, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://mrr.cm/J8v

Related Reports;

Global DNA Sequencing Products Market 2016-2020 - Visit at - http://mrr.cm/JXk

rhEPO Market in China 2016-2020 - Visit at - http://mrr.cm/JX4

United States Sleep Apnea Diagnostic and Therapeutic Devices Industry 2016 New Report Now Available From MarketResearchReports.com

The United States Sleep Apnea Diagnostic and Therapeutic Devices Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Sleep Apnea Diagnostic and Therapeutic Devices industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Sleep Apnea Diagnostic and Therapeutic Devices market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Sleep Apnea Diagnostic and Therapeutic Devices industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 153 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Spanning over 138 pages “United States Sleep Apnea Diagnostic and Therapeutic Devices Industry 2016 Market Research Report” report covers Industry Overview, Manufacturing Cost Structure Analysis of Sleep Apnea Diagnostic and Therapeutic Devices, Technical Data and Manufacturing Plants Analysis, Production Analysis of Sleep Apnea Diagnostic and Therapeutic Devices by Regions, Type, and Applications, Consumption Volume and Consumption Value Analysis of Sleep Apnea Diagnostic and Therapeutic Devices by Regions, Analysis of Sleep Apnea Diagnostic and Therapeutic Devices Production, Supply, Sales and Market Status 2011-2016, Analysis of Sleep Apnea Diagnostic and Therapeutic Devices Industry Key Manufacturers, Price and Gross Margin Analysis, Marketing Trader or Distributor Analysis of Sleep Apnea Diagnostic and Therapeutic Devices, Development Trend of Sleep Apnea Diagnostic and Therapeutic Devices Industry 2016-2021, Industry Chain Suppliers of Sleep Apnea Diagnostic and Therapeutic Devices with Contact Information, New Project Investment Feasibility Analysis of Sleep Apnea Diagnostic and Therapeutic Devices, Conclusion of the United States Sleep Apnea Diagnostic and Therapeutic Devices Industry 2016 Market Research Report.

For more information Visit at: http://mrr.cm/J8m

Related Reports :

Global Robotic Surgery Systems Industry 2016 Market Research Report - Visit at - http://mrr.cm/J8e

Global Viral Hepatitis and Retrovirus Diagnostic Tests Industry 2016 Market Research Report - Visit at - http://mrr.cm/J8X

World Medical/Diagnostic Imaging Market is expected to reach $45.0 Billion by 2022; Finds New Report

Medical/Diagnostic Imaging Market, projects that the world medical imaging market would reach $45.0 billion by 2022, registering a CAGR of 5.1% from 2015 to 2022. X-ray imaging systems is expected to continue to be the highest revenue-generating segment throughout the forecast period. North America accounted for around one-third of the market share in 2015, and is expected to dominate the overall market during the study period.

The major factors boosting the market growth include technological advancements, rising incidence of chronic diseases, and increasing geriatric population worldwide. In addition, increase in number of medical imaging procedures, and rising awareness for early diagnosis of clinical disorders are anticipated to further drive the demand for healthcare services in the world medical imaging market. However, scarcity of helium, high cost of imaging technologies, and unfavorable reimbursement scenario in the emerging economies are some of the factors restricting the market growth.

The cardiovascular and thoracic disease application segment is projected to maintain its lead throughout the analysis period owing to increase in the number of medical imaging services and technological advancements. In addition, technological innovations in the imaging industry have facilitated the development of cost-effective and smaller point-of-care ultrasound systems for cardiac evaluation. Mammography systems has emerged as the fastest growing segment, registering a CAGR of 8.3%, in terms of revenue, during the forecast period. Innovation and digitalization of mammography devices are the major factors contributing to this segments growth.

Geographically, the Asia-Pacific region accounted for the majority of the share in the medical/diagnostic imaging market in 2015, and is expected to maintain this lead throughout the forecast period. This is mainly attributed to the improving healthcare infrastructure and healthcare expenditures in the emerging markets (such as India and China) to overcome the unmet medical needs in these countries. However, LAMEA is projected to be the fastest growing region throughout the analysis period. Increasing incidence of chronic disorders (such as heart disease, cancer, and diabetes) and rapidly growing geriatric population drive the LAMEA medical/diagnostic imaging market.

Key findings of the study:

• In 2015, X-ray imaging systems was the highest revenue-generating segment, accounting more than one-fourth of the overall market revenue, and is projected to grow at a CAGR of 3.7% during the forecast period.
• The mammography systems segment is expected to grow at a remarkable CAGR of 8.3%, owing to the innovation and digitalization of mammography devices.
• Asia-Pacific accounted for about one-third share of the world medical imaging market in 2015.
• The cardiovascular and thoracic application segment is projected to maintain its lead in the market until 2022.
• China and Japan are the major shareholders in the Asia-Pacific region, jointly accounting for more than 50% share of the Asia-Pacific medical imaging market.

The key players profiled in this report include GE Healthcare, Philips Healthcare, Hitachi Medical Corporation, Hologic, Inc., Siemens Healthcare, Samsung Medison, Shimadzu Corporation, Toshiba Medical Systems Corporation, Esaote S.P.A, and Fujifilm Corporation.

For more information Visit at: http://mrr.cm/J7B

Find all Diagnostics Reports at: http://www.marketresearchreports.com/diagnostics

World Biopsy Devices Market is expected to reach $2,399 Million by 2022; Finds New Report

Biopsy Devices Market, states that the world biopsy devices market generated $1,621 million in 2015. The MRI-guided biopsy segment held a dominant share in 2015, and is expected to maintain this trend over the forecast period.

The world biopsy devices market is poised to grow at a CAGR of 5.5% from 2016 to 2022, owing to increase in several types of cancer such as breast, prostate, & lung, and rapid technological advancements in the field of diagnostics. The emerging economies have witnessed an upsurge in the prevalence of chronic diseases due to increase in the aged population and change in lifestyles. Emergence of novel biopsy techniques and advanced integrated imaging technology, such as MRI, CT, ultrasound scan, and others, are expected to supplement the diagnosis of chronic diseases namely, cancer using biopsy procedures. However, high cost associated with advanced biopsy technologies may restrict the market growth.

Breast biopsy application segment is expected to continue to lead the market because of increased incidences and mortality rates of breast cancer. Moreover, initiatives by various government bodies to spread the awareness about breast cancer is expected to supplement the growth of the breast biopsy devices market. Breast biopsy is followed by liver & bile duct biopsy, which is the second highest revenue-generating application segment globally.

Key findings of the study:

• CT-guided biopsy segment is anticipated to grow at the highest CAGR of 6.3% during the forecast period.
• The diagnostic centers would continue to lead the revenue generating end use segment by garnering around half of the share in the overall market.
• Lung biopsy is projected to be the fastest growing application segment, registering a CAGR of 7.0%.
• The robotic guidance system segment is expected to register the highest CAGR of 7.0%.
• The Asia-Pacific region is projected to be the fastest growing market, with a CAGR of 7.2%.
• Hospitals are projected be the fastest growing end use segment, owing to increase in integration of diagnostic facilities within the premises.

North America was the highest revenue generating region due to rise in incidences of chronic diseases in 2015. North America and Europe, collectively, accounted for more than three-fourths of the overall market in 2015; this trend is likely to continue over the forecast period. Factors that drive the growth of biopsy devices in the developed regions are awareness about cancer diagnosis, high purchasing power, and availability of skilled personnel to perform biopsy procedures.

The key companies profiled in the report are C.R. Bard, Inc., Leica Biosystems, Hologic, Inc., Becton, Dickinson and Company, Ethicon EndoSurgery Inc., Fujifilm Medical Systems, Veran Medical Technologies, Boston Scientific Corporation, MDxHealth, Mauna Kea Technologies, Cook Medical, Inc., Medtronic, Argon Medical Devices, Inc, Intact Medical Corp., and others.

For more information Visit at: http://mrr.cm/J7X

Find all Medical Devices Reports at: http://www.marketresearchreports.com/medical-devices 

Global Ophthalmic Diagnostic Devices Industry 2016 New Report Now Available From MarketResearchReports.com

The Global Ophthalmic Diagnostic Devices Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Ophthalmic Diagnostic Devices industry.

Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Ophthalmic Diagnostic Devices market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.

Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the Ophthalmic Diagnostic Devices industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Spanning over 159 pages “Global Ophthalmic Diagnostic Devices Industry 2016 Market Research Report” report covers Industry Overview of Ophthalmic Diagnostic Devices, Manufacturing Cost Structure Analysis of Ophthalmic Diagnostic Devices, Technical Data and Manufacturing Plants Analysis of Ophthalmic Diagnostic Devices, Capacity, Production and Revenue Analysis of Ophthalmic Diagnostic Devices by Regions, Types and Manufacturers, Price, Cost, Gross and Gross Margin Analysis of Ophthalmic Diagnostic Devices by Regions, Types and Manufacturers, Consumption Volume, Consumption Value and Sale Price Analysis of Ophthalmic Diagnostic Devices by Regions, Types and Applications, Supply, Import, Export and Consumption Analysis of Ophthalmic Diagnostic Devices, Major Manufacturers Analysis of Ophthalmic Diagnostic Devices, Marketing Trader or Distributor Analysis of Ophthalmic Diagnostic Devices, Industry Chain Analysis of Ophthalmic Diagnostic Devices, Development Trend of Analysis of Ophthalmic Diagnostic Devices, New Project Investment Feasibility Analysis of Ophthalmic Diagnostic Devices, Conclusion of the Global Ophthalmic Diagnostic Devices Industry 2016 Market Research Report.

For more information Visit at: http://mrr.cm/J7t

Related Reports :

Global Overactive Bladder Industry 2016 Market Research Report - Visit at - http://mrr.cm/J7v

Global Eye Care Surgical Consumption 2016 Market Research Report - Visit at - http://mrr.cm/J8k

Global Joint Repair Devices in Sports Medicine Industry 2016 New Report Now Available From MarketResearchReports.com

The Global Joint Repair Devices in Sports Medicine Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Joint Repair Devices in Sports Medicine industry.

Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Joint Repair Devices in Sports Medicine market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.

Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the Joint Repair Devices in Sports Medicine industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Spanning over 154 pages “Global Joint Repair Devices in Sports Medicine Industry 2016 Market Research Report” report covers Industry Overview of Joint Repair Devices in Sports Medicine, Manufacturing Cost Structure Analysis of Joint Repair Devices in Sports Medicine, Technical Data and Manufacturing Plants Analysis of Joint Repair Devices in Sports Medicine, Capacity, Production and Revenue Analysis of Joint Repair Devices in Sports Medicine by Regions, Types and Manufacturers, Price, Cost, Gross and Gross Margin Analysis of Joint Repair Devices in Sports Medicine by Regions, Types and Manufacturers, Consumption Volume, Consumption Value and Sale Price Analysis of Joint Repair Devices in Sports Medicine by Regions, Types and Applications, Supply, Import, Export and Consumption Analysis of Joint Repair Devices in Sports Medicine, Major Manufacturers Analysis of Joint Repair Devices in Sports Medicine, Marketing Trader or Distributor Analysis of Joint Repair Devices in Sports Medicine, Industry Chain Analysis of Joint Repair Devices in Sports Medicine, Development Trend of Analysis of Joint Repair Devices in Sports Medicine, New Project Investment Feasibility Analysis of Joint Repair Devices in Sports Medicine, Conclusion of the Global Joint Repair Devices in Sports Medicine Industry 2016 Market Research Report.

For more information Visit at: http://mrr.cm/J7A

Related Reports :

Europe Glaucoma Surgical Devices Industry 2016 Market Research Report - Visit at - http://mrr.cm/J7d

Global Anesthesia Delivery Systems Consumption 2016 Market Research Report - Visit at - http://mrr.cm/J7P

Global Health Care Industry 2016 Market Report; Launched via MarketResearchReports.com

2016 Global Health Care Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Health Care industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

The report firstly introduced the Health Care basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Health Care industry; 3.) the North American Health Care industry; 4.) the European Health Care industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

Spanning over 156 pages “Global Health Care Industry 2016 Market Research Report” report covers Health Care Industry Overview, Asia Health Care Industry, North American Health Care Industry, Europe Health Care Industry Analysis, Health Care Marketing Channels and Investment Feasibility, Global Health Care Industry Conclusions.

For more information Visit at: http://mrr.cm/J7g

Related Reports;

Global Hot and Cold Therapy Packs Industry 2016 Market Research Report; visit at - http://mrr.cm/J7M

Global Ostomy Products Industry 2016 Market Research Report; visit at - http://mrr.cm/J7Q

Global Brachytherapy Devices Industry 2016 New Report Now Available From MarketResearchReports.com

The Global Brachytherapy Devices Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Brachytherapy Devices industry.

Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Brachytherapy Devices market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.

Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the Brachytherapy Devices industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Spanning over 151 pages “Global Brachytherapy Devices Industry 2016 Market Research Report” report covers Industry Overview of Brachytherapy Devices, Manufacturing Cost Structure Analysis of Brachytherapy Devices, Technical Data and Manufacturing Plants Analysis of Brachytherapy Devices, Capacity, Production and Revenue Analysis of Brachytherapy Devices by Regions, Types and Manufacturers, Price, Cost, Gross and Gross Margin Analysis of Brachytherapy Devices by Regions, Types and Manufacturers, Consumption Volume, Consumption Value and Sale Price Analysis of Brachytherapy Devices by Regions, Types and Applications, Supply, Import, Export and Consumption Analysis of Brachytherapy Devices, Major Manufacturers Analysis of Brachytherapy Devices, Marketing Trader or Distributor Analysis of Brachytherapy Devices, Industry Chain Analysis of Brachytherapy Devices, Development Trend of Analysis of Brachytherapy Devices, New Project Investment Feasibility Analysis of Brachytherapy Devices, Conclusion of the Global Brachytherapy Devices Industry 2016 Market Research Report.

For more information Visit at: http://mrr.cm/Jhr

Related Reports :

Global COPD and Asthma Devices Industry 2016 Market Research Report - Visit at - http://mrr.cm/JhH

Global Bone Graft and Substitutes Industry 2016 Market Research Report - Visit at - http://mrr.cm/JhV

Global Spectrometry Market is expected to reach $20,075 million by 2022; Finds New Report

Spectrometry is a technology or combination of two which make use of electromagnetic radiations for qualitative and quantitative sample analysis so as to obtain structural data and identify chemical makeup of a sample. Spectrometry measurements with rapid and accurate information results in improved productivity & efficiency, better quality of the transformed products with reduced cost and decreased waste products.

The global spectrometry market is valued to be $XX million in 2015 and poised to grow at a CAGR of X% to reach $20,075 million by 2022. Spectrometry market is mainly classified into technology, application and end-users and geography. The global spectrometry market by technology is further divided into atomic spectrometry, mass spectrometry and molecular spectrometry.

The atomic spectrometry market is further divided into atomic absorption spectrometry (AAS), X-ray diffraction spectrometry (XRD), X-ray fluorescence spectrometry (XRF),  X-ray photoelectron spectrometry (XPS), inductively coupled plasma-atomic emission spectrometer (ICP-AES), elemental analyzers and others which includes arc/spark optical emission spectrometry and glow discharge optical emission spectrometry (GD-OES).

The mass spectrometry includes gas chromatography-mass spectrometry (GC-MS), liquid chromatography-mass spectrometry (LC-MS), inductively coupled plasma mass spectrometry (ICP-MS), Magnetic sector mass spectrometry (MSMS), Fourier transform mass spectrometry (FTMS) and others. The gas chromatography-mass spectrometry (GC-MS) is further sub-segmented into single quadrupole gas chromatography-mass spectrometry (SQ GC-MS), triple-quadrupole gas chromatography-mass spectrometry (TQ GC-MS), quadrupole-time of flight gas chromatography-mass spectrometry (QToF GC-MS) and others (orbitrap). The liquid chromatography-mass spectrometry (LC-MS) is sub-segmented into single quadrupole liquid chromatography-mass spectrometry (SQ LC-MS), triple-quadrupole liquid chromatography-mass spectrometry (TQ LC-MS), quadrupole-time of flight liquid chromatography-mass spectrometry (QToF LC-MS) and others (orbitrap). Inductively coupled plasma mass spectrometry (ICP-MS) includes single quadrupole ICP-MS, high resolution ICP-MS and multicollector ICP-MS. Lastly, the others segment contains secondary ion mass spectrometry (SIMS) and matrix-assisted laser desorption/ionization-time of flight spectrometry (MALDI-TOF).

Molecular spectrometry is classified into nuclear magnetic resonance spectrometry (NMR), ultraviolet visible spectrometry (UV-Vis), infrared spectrometry (IR), color measurement and Raman spectrometry. The nuclear magnetic resonance is sub-segmented into continuous wave, fourier transform and solid state NMR. The ultraviolet visible spectrometry is further classified into single beam, double beam and array based UV-visible spectrometry. Infrared segment includes near infrared (NIR), mid infrared (MIR) and far infrared spectrometry (FIR). Color measurement includes luminescence which is further sub-segmented into fluorescence spectrometry. Raman spectrometry is further classified into fourier transform, surface enhancing and micro Raman spectrometry.

The spectrometry application market includes agriculture, food and beverage, biotechnology, pharmaceuticals, environmental testing, chemical industry, semiconductors/electronics/nanotechnology and others which include forensic, geology, petrochemical industry, defence industries, cosmetics, archaeology, marine emission control (MEC), material science, oil and gas and automotive.

Among the spectrometry technology type, the Molecular spectrometry segment dominated the market by occupying a largest share of XX%. At the same time, mass spectrometry market is the fastest growing segment with a CAGR of 8.9% from 2015 to 2022. In applications, pharmaceuticals segment holds the largest share of 32.9% and semiconductors/electronics/nanotechnology is the fastest growing segment with a CAGR of X% from 2015 to 2022. Geographical wise, North America is the largest market, with a share of XX% followed by Europe, Rest of the World and Asia. The Asia-Pacific region is the fastest growing region with a CAGR of X% from 2015 to 2022 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the spectrometry market. Growth in Asia-Pacific market is attributed to increased funding from the corresponding governments for research activities, technological advancements, increased pharmaceutical and biotechnological research.

The spectrometry market is expected to grow steadily at a CAGR of X% during 2015 to 2022. The factors driving the growth of this market are increased use of handheld and portable spectrometer devices, high rate influx of innovative products, increasing demand from emerging countries and fund allotment from government organizations and companies are likely to propel the spectrometry market.

However, complex regulatory guidelines, huge capital investments and shortage of skilled technicians are hampering the growth of the market. The threat for the spectrometry market includes unfavourable economic conditions and political instability that leads to reduced product sales.

The spectrometry global market is a highly fragmented market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the spectrometry market are AB Sciex (U.S.), Agilent Technologies Inc (U.S.), Analytik Jena AG (Germany), Biomerieux (France), Bruker Corporation (U.S.), Horiba (Japan), Perkin Elmer (U.S.), Shimadzu Corporation (Japan), Thermo Fisher Scientific Inc (U.S.), and Waters Corporation (U.S.).

The report provides an in depth market analysis of the above mentioned segments across the following regions:

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Spanning over 466 pages “Spectrometry Global Market - Forecast to 2022” report covers Executive Summary, Introduction, Market Analysis, Spectrometry Global Market, By Technology, Spectrometry Global Market, By Applications, Regional Analysis, Competitive Landscape, Major Companies.

For more information Visit at: http://mrr.cm/Jhe

Find all Biotechnology Reports at: http://www.marketresearchreports.com/biotechnology

Vietnam Phamaceutical Report Q2/2016 Market Report; Launched via MarketResearchReports.com

With 178 drug manufacturers Vietnam pharmaceutical products mostly focus on simple dosage forms and generic form with lower values and overlapping, and completely lack effective drugs with complicated preparation. On the other hand, there are a huge number of companies in generic drugs market, which is very small, then leading to decrease in profits. Vietnam Pharmaceutical industry uses about 60,000 tons of medicines, of which about 80-90% is imported. The ratio of research & development expense to revenue at domestic companies is just about 5%.

In 2015, according to Publisher estimation, Pharmaceutical industry value is expected to reach US$4.2bn. Although pharmaceutical spending per capita in 2015, according to Publisher’s estimation, is US$38. The growth of the prescription drug market will exceed the growth rate of Over-the-counter (OTC) market.

The market value of patented drugs in Vietnam tends to increase gradually. Pharmaceutical imports in 2015 reached US$2.3bn, mainly from France (US$275m) and India US$267m).

Pharmaceutical exports in Vietnam reached relatively low rate of 5% of the import value and 2.5% of the industry consumption value. The biggest wholesale market systems in Vietnam pharmaceutical distribution in Ho Chi Minh City and Hanoi. Pharmaceutical products are necessities, thus, economic growth virtually has hardly any impact on the industry growth rate. Some main industry driving forces are the protection from state.

To compromise WTO agendas, Vietnam has to gradually open the pharmaceutical market by allowing foreign firms to built plants and distribution network in Vietnam. With higher level of opening after the TPP, domestic pharmaceutical companies will face the threat of more competition from FDI ones.

Vietnam Pharmaceutical industry is forecast to continue the double-digit growth. Most of the enterprises of pharmaceutical industry maintained positive operation with high levels of gross profit and net profit in the period 2014-2015. In addition, raising awareness of consumers on health issues and initiative in healthcare also contributed greatly to industry development. With higher disposable incomes, consumers seem to be more interested in vitamins and supplements to diets.

The in-depth research “Vietnam Pharmaceutical Industry” carried out by Vietnam Industry Research and Consultant (VIRAC) illustrates the overall scenario of the pharmaceutical industry in Vietnam in order to provide an insight for a better understanding regarding the market. The report details the economic situation in general and the industry in particular with updated date and statistic until 2017, the movement of the price as well as the forecast for the upcoming future, covering all domains. Analysis of big players in the industry is also elaborated by providing detailed financial analysis, applied technology, market share, etc. herein to help companies position and define the competiveness in the market. For example, some typical producers are DHG Pharma JSC, Imexpharm Pharma JSC, Domesco Medical Import Export JSC, TRAPHACO JSC, S.P.M JSC.

Spanning over 109 pages “Vietnam Phamaceutical Report Q2/2016” report covers Executive Summary, Business Environment, Overview of Vietnam Pharmaceutical Industry, Enterprise Analysis.

For more information Visit at: http://mrr.cm/Jhi

Find all Pharmaceutical Manufacturing Reports at: http://www.marketresearchreports.com/pharmaceutical-manufacturing 

Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs; New Report Launched

Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs", discusses global commercial trends and prospects for human medicines applied in the veterinary setting, also called crossover drugs. A wide range of human drugs continue to be applied in the veterinary space due to a lack of approved animal therapies, convenience and the rising costs of veterinary research.

This new report provides insights into Extra-label Drug Use (ELDU), its application in the veterinary setting and other guidelines and regulations followed by professionals in the animal health industry. Through a series of in-depth case studies this report provides insights into the rationale for the transition of several human drugs to the veterinary setting as well as disease overviews, competing treatments, manufacturer information, dosage forms, cost of therapy and other insightful marketing information. Our new study also identifies and explores important drivers and restraints of the crossover drugs market.

Information leveraged from our robust industry-leading database shows a diverse range of marketed human drugs being used in companion animals especially cats, dogs and horses. Our new report includes detailed profiles of key animal health companies with diverse portfolios of crossover drugs as well as strategies being employed by competitors in this market to leverage human therapies into the veterinary space. Additionally, we identify emerging companies marketing various crossover drugs across a range of therapy areas.

Publisher conducted extensive research in order to provide a comprehensive view of the current trends and commercial prospects for crossover drugs. This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising commercial areas in the market and exploit key business opportunities.

Scope

• What regulations need to be followed when prescribing human drugs off-label to pets and food-producing animals?
• What are the main factors driving the prescription of human medicines in animals?
• Marketed human drugs commonly used in companion animals
• What are the differences in indication between the human and veterinary setting?
• What are the dosage and side effects of those specific drugs in animals?
• Are there any existing and approved veterinary therapies for the same indication? Why is the human drug preferred over the approved animal drug?
• What are the key drivers and barriers that affect ELDU of human drugs in animals?
• What is currently restricting the crossover drugs market?
• What are the key animal health companies with prominent crossover drug portfolios?
• Explore recent financial performance, crossover drugs brands, and the number of species supported through their animal health product portfolio
• Identify emerging companies in the animal health market investigating and marketing crossover drugs

Reasons to buy

This report will allow you to -

• Gain insightful analyses and understanding of the crossover drugs market: This report describes and assesses the key differences between the human and animal healthcare markets, areas of unmet need in the veterinary market and key factors responsible for ELDU in the veterinary setting.
• Assess high-profile marketed human products used for treating animals: Our new study provides analyses of the key human therapies that have the potential to be transitioned in the veterinary space.
• Identify the most important drivers and restraints of the crossover drugs market: This report provides insights regarding what is currently driving the prescription and application of human drugs in the veterinary setting as well as the current factors restraining further transition.
• Review the key and emerging companies that market crossover drugs and the business strategies being employed: This report assesses current tactics used by top veterinary pharmaceutical companies in manufacturing and marketing cross-over drugs. It also reviews the emerging companies that manufacture cross-over drugs for various indications.
• Assess future trends in the veterinary market: This report contains our prediction for what the future holds for crossover drugs, future treatment landscapes and evolving marketing models.

For more information Visit at: http://mrr.cm/JhJ

Find all Treatments Reports at: http://www.marketresearchreports.com/treatments

Global Reverse Shoulder Prostheses Consumption 2016 New Report Now Available From MarketResearchReports.com

The Global Reverse Shoulder Prostheses Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Reverse Shoulder Prostheses market.

First, the report provides a basic overview of the Reverse Shoulder Prostheses industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.

Secondly, the report states the global Reverse Shoulder Prostheses market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed.

Third, the Reverse Shoulder Prostheses market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What’s more, the Reverse Shoulder Prostheses industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Spanning over 170 pages “Global Reverse Shoulder Prostheses Consumption 2016 Market Research Report” report covers Industry Overview of Reverse Shoulder Prostheses, Manufacturing Cost Structure Analysis of Reverse Shoulder Prostheses, Global Market Size (Volume and Value), Sales and Sale Price Analysis of Reverse Shoulder Prostheses, USA Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Reverse Shoulder Prostheses, Europe Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Reverse Shoulder Prostheses, China Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Reverse Shoulder Prostheses, Japan Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Reverse Shoulder Prostheses, Major Manufacturers Analysis of Reverse Shoulder Prostheses, Global Production Analysis of Reverse Shoulder Prostheses by Regions, Global and Major Regions Market Size (Volume and Value) Forecast of Reverse Shoulder Prostheses, Marketing Trader or Distributor Analysis of Reverse Shoulder Prostheses, New Project Investment Feasibility Analysis of Reverse Shoulder Prostheses, Conclusion of the Global Reverse Shoulder Prostheses Consumption 2016 Market Research Report.

For more information Visit at: http://mrr.cm/Jhb

Related Reports :

Global ECG Simulator Consumption 2016 Market Research Report - Visit at - http://mrr.cm/JhE

Global External Fixation Systems Consumption 2016 Market Research Report - Visit at - http://mrr.cm/Jha

Global Dialysis Devices Market is expected to reach $19,289 million by 2022; Finds New Report

The dialysis devices global market is expected to grow at a mid range single digit CAGR to reach $19,289 million by 2022. Dialysis is the treatment method for the patients with kidney failure, it replaces the function of kidneys by removing the wastes and excess fluid from the patient’s blood and thus the treatment helps to keep the patient body’s electrolytes such as sodium, potassium and chloride in balance.

Increasing number of ESRD patients & substantial healthcare expenditure on the treatment of end-stage renal disease (ESRD), growing number of patients suffering from diabetes and hypertension, rise in aging population, rising adoption of dialysis procedures over renal transplants, technological advancements and new product launches are driving the market growth.

Risk and complications associated with dialysis, product recalls, limited reimbursements for dialysis in developing countries, reimbursement cuts for dialysis in North America and stringent regulatory policies for the approval of new dialysis devices.

The dialysis devices global market by type is mainly segmented into hemodialysis and peritoneal dialysis. Hemodialysis market further segmented by products into machines and consumables, and by modalities into conventional long-term hemodialysis, short daily hemodialysis, and nocturnal hemodialysis. Hemodialysis machines sub-segmented into center-use hemodialysis machines and home-use hemodialysis machines whereas the hemodialysis consumables sub-segmented into dialyzers, access products, bloodlines, concentrates/dialysate, water treatment systems and other hemodialysis consumables. The dialyzers further segmented as cellulose-based and synthetic dialyzers based on material type, and high-flux and low-flux dialyzers based on flux type. Hemodialysis access products are further segmented as arteriovenous (AV) fistula, A-V Graft and central venous catheter (CVC). Hemodialysis water treatment systems mainly segmented as central water disinfection systems and portable water disinfection systems and these further segmented as chemical disinfection systems, heat disinfection systems and accessories individually. Peritoneal dialysis market segmented into peritoneal dialysis concentrate/dialysate, machines, catheters, transfer sets and others by-products, and continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) by modality.

The dialysis devices market by end-users is mainly segmented into In-Center dialysis and Home dialysis. The In-Centre dialysis further segmented into Hospital dialysis and Dialysis Centers whereas the Home dialysis is further segmented into Peritoneal Dialysis and Home Hemodialysis.

The dialysis devices global market by geography is divided into North America, Europe, Asia-Pacific and Rest of the World (RoW). Europe region commanded the largest market share.  Increasing incidence of end-stage renal disease (ESRD), increasing hemodialysis facilities, increasing aging populations and increasing awareness of dialysis therapies are driving the European dialysis devices market growth. However, Asia-Pacific region is the fastest growing region due to growing number of ESRD patients, increasing healthcare expenditure, increasing awareness of healthcare, and refining healthcare infrastructure in the emerging countries, such as India and China.

Major players in dialysis devices global market include are Asahi Kasei Corp. (Japan), B. Braun Melsungen AG (Germany), Baxter International, Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), JMS Co. Ltd. (Japan), Kawasumi Laboratories (Japan), Nikkiso Co., Ltd. (Japan), Nipro Corporation (Japan), NxStage Medical Inc. (U.S.) and Toray Industries Inc. (Japan).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Spanning over 398 pages “Dialysis Devices Global Market - Forecast to 2022” report covers Executive Summary, Introduction, Market Overview, Dialysis Devices Global Market, By Type, Dialysis Devices Global Market, By End-Users, Dialysis Devices Global Market, By Region, Company Developments, Major Companies. The report covered companies are - Asahi Kasei Corp., B.Braun Melsungen Ag, Baxter International, Inc., Fresenius Se & Co. Kgaa, Jms Co. Ltd., Kawasumi Laboratories, Inc., Nikkiso Co., Ltd, Nipro Corporation, Nxstage Medical, Inc., Toray Industries Inc., List Of Companies Mentioned In The Report, Allmed Medical Gmbh, Amecath, Angiodynamics.

For more information Visit at: http://mrr.cm/Jn3

Find all Medical Devices Reports at: http://www.marketresearchreports.com/medical-devices